New progress in diagnosis and treatment of pulmonary arterial hypertension
Abstract Pulmonary arterial hypertension (PAH) is a progressive disease. Although great progress has been made in its diagnosis and treatment in recent years, its mortality rate is still very significant. The pathophysiology and pathogenesis of PAH are complex and involve endothelial dysfunction, ch...
Main Authors: | Zai-qiang Zhang, Sheng-kui Zhu, Man Wang, Xin-an Wang, Xiao-hong Tong, Jian-qiao Wan, Jia-wang Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Journal of Cardiothoracic Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13019-022-01947-y |
Similar Items
-
Chronic pulmonary arterial hypertension in children
by: A.D. Bruwer, et al.
Published: (2017-04-01) -
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
by: M. Humbert
Published: (2010-03-01) -
THE ROLE OF RIOCIGUAT IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE
by: O. Ya. Vasiltseva, et al.
Published: (2019-12-01) -
Evolution of pathogenetic therapy of pulmonary arterial hypertension
by: I E Chazova, et al.
Published: (2019-12-01) -
Serum proteome profiling reveals HGFA as a candidate biomarker for pulmonary arterial hypertension
by: Meng Zhang, et al.
Published: (2024-11-01)